ArticleActa pharmacologica Sinica2025

Discovery of novel dual-target inhibitors of LSD1/EGFR for non-small cell lung cancer therapy.

Yu Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.